Please assess the completion status of the following clinical trial:

Trial Title: Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Newly diagnosed patients (\< 3years) with type 2 diabetes.~* Fasting plasma glucose (FPG) range of 126-240 mg/dL at Screening.~* No previous treatment with oral or parenteral glucose-lowering therapy.~Exclusion criteria:~* History of lactic acidosis.~* Anemia (\<11g for males, \<10 g for females).~* Unstable or severe NY Heart Association-class 3 or 4.~* Any NY Heart Association congestive heart failure.~* Patients with chronic diseases requiring periodic or intermittent treatment with oral or intravenous corticosteroids.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).